Shaw and Partners have initiated coverage on MCP with a $1.85 price target medium term !
They state: "The stock trades at 13x FY18 P/E, which is hardly a stretch with small cap industrials trading at around 18x and global health and beauty peers at more than 20x FY18 P/E."
Still good value and hopefully will drive new investors to invest in MCP.
Add to My Watchlist
What is My Watchlist?